Daily Edition · Page 3

THE DAILY INDEX

Technology, AI, software, security, crypto and business

HEADLINES & LAUNCHES

TLDR AI

MATHEMATICIANS USE AI TO IDENTIFY EMERGING COVID-19 VARIANTS

University of Manchester mathematicians have developed an AI tool, CLASSIX, to rapidly identify emerging COVID-19 variants from genetic data, potentially streamlining the tracking of viral evolution and aiding in proactive responses like tailored vaccine development. The method, which is computationally less demanding than traditional phylogenetic analysis, processed 5.7 million sequences in 1-2 days on a standard laptop, demonstrating its efficiency in managing large-scale genomic data. The research signifies a step towards quicker, resource-efficient identification of significant pathogen strains.

TRENDS IN SYNTHETIC BIOLOGY & AI IN DRUG DISCOVERY IN 2024

2024 is set to be a monumental year for AI in drug discovery, marking considerable advancements in synthetic biology. This article highlights key trends, including generative AI's influence on science and the synthesis of modular biological components. AI's integration with synthetic biology is accelerating the drug discovery process, as demonstrated by Insilico Medicine's AI-powered candidate's progression to Phase II clinical trials.

LLMS HAVE SPECIAL INTELLIGENCE, NOT GENERAL, AND THAT'S PLENTY

Anthropic's new AI model Claude-3 surpasses the average human IQ and outperforms other models, including GPT-4, in advanced cognitive tasks. Despite this achievement, Claude-3 still struggles with basic challenges like puzzles that humans find easy. LLMs may possess a 'Special Intelligence' rather than human-like general intelligence. They could be reflecting our knowledge back to us in innovative ways.

TLDR IndexPage 3